FARYDAK, a histone deacetylase inhibitor, in combination with bortezomib and dexamethasone, is indicated for the treatment of patients with multiple myeloma who have received at least 2 prior regimens, including bortezomib and an immunomodulatory agent. This indication is approved under accelerated approval based on progression free survival. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of FARYDAK (panobinostat) capsules brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the FARYDAK (panobinostat) capsules medicine cost price in India.
The order for FARYDAK (panobinostat) capsules will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Panobinostat is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Panobinostat is used in combination with other drugs to treat multiple myeloma.
FARYDAK® (panobinostat) capsules, for oral use Initial U.S. Approval: 2015
Generic Name: panobinostat
Capsules: 10 mg, 15 mg, and 20 mg
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand FARYDAK (panobinostat) capsules on prescription and Import License in Patient's Name only.
For overseas patients, FARYDAK (panobinostat) capsules can be made available in Send your enquiry to find FARYDAK (panobinostat) capsules in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For FARYDAK (panobinostat) capsules Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Secura Bio Acquires Global Rights To Farydak® For More Details
Novartis bags a surprise approval for the blood cancer-treating panobinostat For More Details